Skip to content

Correlation between the Whole-body Fat MRI Quantitative and Ischemic Heart Disease

Correlation between the Whole-body Fat MRI Quantitative and Ischemic Heart Disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300070489
Enrollment
Unknown
Registered
2023-04-13
Start date
2023-04-15
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Heart Disease

Interventions

Sponsors

Guangxi Zhuang Autonomous Region People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients suspected to be coronary heart disease based on clinical manifestations and laboratory examination and undergoing coronary CTA or DSA examination; Patients gave informed consent to this study. 2. Diagnostic criteria for coronary heart disease: DSA or coronary CTA examination showed that the internal diameter of at least one major branch of coronary artery was stenosis >=50%. 3. Diagnostic criteria for non-coronary heart disease: (1) Initial rule of myocardial ischemia by ECG in outpatient or inpatient; (2) Negative cardiac biomarkers; (3) DSA or coronary CTA examination showed no stenosis or mild stenosis (stenosis > 30% and < 50%) in the main branches of the coronary artery.

Exclusion criteria

Exclusion criteria: 1. Unable to cooperate with the completion of the corresponding assessment and inspection and quit midway; 2. MRI image quality does not meet the requirements; 3. Patients with acute and chronic infectious diseases, acute heart failure, and chronic cardiac insufficiency (NYHA cardiac function grade ? ~ ?) were excluded; 4. Contraindications to MRI examination (e.g., inability to remove metal implants such as prosthetic heart valves, pacers, or others, claustrophobia, etc.).

Design outcomes

Primary

MeasureTime frame
visceral fat area;subcutaneous fat area;epicardial adipose tissue area;visceral fat area/subcutaneous fat area;

Secondary

MeasureTime frame
serum lipid;body mass index;waist circumference;hip circumference;waist-to-hip ratio;neck circumference;

Countries

China

Contacts

Public ContactCui Meng

Guangxi Zhuang Autonomous Region People's Hospital

360238158@qq.com+86 15977472133

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026